• LAST PRICE
    3.3600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.4000/ 8
  • Ask / Lots
    5.3700/ 1
  • Open / Previous Close
    0.0000 / 3.3600
  • Day Range
    ---
  • 52 Week Range
    Low 1.6600
    High 7.1900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.74
TimeVolumeTNYA
09:32 ET19713.66
09:38 ET6003.6301
09:39 ET2003.66
09:41 ET1003.66
09:43 ET2053.65
09:50 ET2003.62
09:52 ET5883.6
09:54 ET1003.57
09:56 ET13003.56
09:59 ET2653.57
10:01 ET1003.55
10:03 ET52833.51
10:06 ET69443.54
10:08 ET135503.555
10:12 ET12743.54
10:15 ET2003.5
10:17 ET5133.5
10:19 ET29013.48
10:21 ET29013.48
10:24 ET1003.47
10:26 ET1003.47
10:28 ET66053.485
10:33 ET3003.48
10:39 ET1003.45
10:44 ET1003.45
10:48 ET20083.49
10:50 ET12883.48
10:57 ET2003.51
11:00 ET8003.5
11:02 ET41003.51
11:04 ET1003.49
11:06 ET1003.48
11:09 ET187343.43
11:11 ET7823.44
11:13 ET8523.45
11:20 ET1003.46
11:29 ET5003.4678
11:31 ET1003.465
11:36 ET1003.465
11:38 ET17003.47
11:40 ET1003.48
11:42 ET2103.46
11:44 ET99313.45
11:45 ET4933.44
11:47 ET7503.4433
11:51 ET1003.43
11:58 ET1253.4334
12:00 ET9003.42
12:02 ET1003.42
12:03 ET1003.42
12:07 ET1003.42
12:09 ET1003.435
12:14 ET2003.44
12:16 ET1003.44
12:20 ET1003.42
12:21 ET3003.446
12:23 ET1003.42
12:27 ET2003.42
12:32 ET10003.39
12:36 ET1003.39
12:38 ET5003.42
12:39 ET2003.415
12:45 ET1003.415
12:48 ET1003.42
12:50 ET1503.4225
12:52 ET1443.4293
12:54 ET1003.41
12:56 ET2383.42
12:57 ET8493.42
01:01 ET1003.41
01:08 ET4003.42
01:10 ET8503.43
01:15 ET10003.43
01:26 ET4003.43
01:30 ET97443.48
01:32 ET2003.47
01:33 ET4003.48
01:35 ET42113.481
01:44 ET3213.45
01:46 ET1003.465
01:48 ET2503.465
01:51 ET1003.45
01:53 ET1003.46
01:55 ET6003.44
02:02 ET1003.42
02:06 ET1003.42
02:08 ET13203.45
02:20 ET1003.44
02:22 ET2003.44
02:24 ET1003.44
02:26 ET5003.4499
02:29 ET16683.44
02:31 ET1003.44
02:36 ET2003.44
02:38 ET5003.42
02:40 ET16503.41
02:42 ET40193.41
02:44 ET1463.42
02:45 ET2003.4
02:47 ET10443.41
02:49 ET83403.4
02:51 ET24523.39
02:54 ET34213.4
02:56 ET10343.41
03:00 ET5003.41
03:02 ET10923.41
03:03 ET2003.42
03:05 ET4003.42
03:07 ET5613.43
03:09 ET40093.42
03:14 ET2003.42
03:16 ET8703.43
03:18 ET1003.4
03:20 ET6003.4
03:23 ET3003.415
03:25 ET1003.415
03:30 ET14703.415
03:32 ET8003.415
03:34 ET3003.4
03:36 ET45953.43
03:38 ET15003.415
03:39 ET1003.4
03:41 ET13993.41
03:43 ET6183.4
03:45 ET4943.405
03:48 ET22823.4
03:50 ET3003.4169
03:52 ET5243.41
03:54 ET335473.35
03:56 ET49893.35
03:57 ET42653.36
03:59 ET385453.36
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTNYA
Tenaya Therapeutics Inc
263.8M
-2.0x
---
United StatesGUTS
Fractyl Health Inc
270.1M
-3.3x
---
United StatesELYM
Eliem Therapeutics Inc
256.3M
-16.5x
---
United StatesIPSC
Century Therapeutics Inc
260.3M
-1.4x
---
United StatesRENB
Renovaro Inc
241.9M
-2.1x
---
United StatesZURA
Zura Bio Ltd
240.1M
-2.3x
---
As of 2024-06-17

Company Information

Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.

Contact Information

Headquarters
171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
Phone
415-865-2066
Fax
302-655-5049

Executives

Independent Chairman of the Board
David Goeddel
Chief Executive Officer, Director
Faraz Ali
Chief Financial and Business Officer
Leone Patterson
Chief Scientific Officer
Timothy Hoey
Chief Medical Officer
Whittemore Tingley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$263.8M
Revenue (TTM)
$0.00
Shares Outstanding
78.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.65
Book Value
$2.04
P/E Ratio
-2.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.